As the AD pathology commonly coexists with that of the vascular dementia, with many of the patients actually being affected by mixed dementia (AD and vascular) [14, 15], the presence of both pathologies - amyloid/tau and vascular impairment- makes our model also representative of AD mixed with vascular dementia. The gene discussed is MAPT; the disease is Alzheimer disease.